drugset / Trial / NCT03260790

Pneumococcal Vaccines in Patients With Asthma

NCT03260790

Phase 4 Completed 17 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelPrevention

Summary

Investigators are assessing if patients with asthma respond better to the Pneumovax vaccine if they are given Prevnar initially.

Timeline

Start
2017-10-01
Primary completion
2020-12-21
Completion
2020-12-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Pneumovax 23 Vaccine 0.5 ml Intramuscular
Subject Prevnar 13 Vaccine 0.5 ml Intramuscular

Indications